Herzlia, Israel

Shiri Freilich

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 338(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Shiri Freilich

Introduction: Shiri Freilich is a prominent inventor based in Herzlia, Israel. With a focus on biotechnology, she has made significant strides in the field of medical research. Her work primarily revolves around human thrombospondin polypeptides, which have crucial implications in various therapeutic applications.

Latest Patents: Shiri Freilich holds a patent for a "Human thrombospondin polypeptide - A human thrombospondin 1 protein, polynucleotide encoding the protein, and pharmaceutical composition thereof." This patent represents her innovative approach towards understanding and utilizing this specific protein in healthcare, showcasing her commitment to advancing medical science.

Career Highlights: She is currently employed at Compugen Ltd., a corporation known for its groundbreaking work in computational medicine and drug discovery. Shiri's contributions to the company reflect her dedication to innovation and the pursuit of novel therapeutic solutions.

Collaborations: Throughout her career, Shiri has collaborated with talented individuals in her field, including coworkers Liat Mintz and Hanqing Xie. These collaborations have fostered a dynamic research environment, allowing her to expand her ideas and further develop her inventions.

Conclusion: Shiri Freilich is a testament to the impactful role of inventors in the biotechnology sector. Her patent not only exemplifies her inventive spirit but also highlights the importance of collaboration in advancing medical research. The work she continues to do at Compugen Ltd. promises to influence the future of healthcare innovations significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…